An In Silico -Guided Approach for Assessing Herb-Drug Interaction Potential: A Case Study with Cudrania tricuspidata Leaf Extracts

被引:0
作者
Seo, Jeong In [1 ,2 ]
Kwak, Young Beom [3 ]
Cho, Seong Eun [1 ,2 ]
Yoo, Hye Hyun [1 ,2 ]
机构
[1] Hanyang Univ, Pharmacomicrobi Res Ctr, Ansan 15588, Gyeonggi Do, South Korea
[2] Hanyang Univ, Coll Pharm, Ansan 15588, Gyeonggi Do, South Korea
[3] Inje Univ, Dept Pharmaceut Engn, Gimhae, South Korea
基金
新加坡国家研究基金会;
关键词
Cudrania tricuspidata; herb-drug interactions; cytochrome P450; in silico; in vitro; quercetin; kaempferol; flavonoids; Moraceae; PHARMACOKINETICS; METABOLISM; RATS;
D O I
10.1055/a-2363-5033
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Cudrania tricuspidata leaf extracts have long been utilized as traditional oriental medicines across Asian countries like Korea, China, and Japan. These extracts are renowned for their therapeutic benefits in addressing inflammation, tumors, obesity, and diabetes, maintaining their status as a pivotal folk remedy. Given the rising trend of combining medicinal herbs with conventional medications, it is imperative to explore the potential herb-drug interactions. However, there is a dearth of research on evaluating the herb-drug interactions of C. tricuspidata leaf extracts. Also, the intricate chemical composition of medicinal herbs presents methodological hurdles in establishing causal relationships between their constituents and herb-drug interactions. To overcome these challenges, a combined in silico and in vitro workflow was developed and effectively applied to evaluate the potential herb-drug interaction of C. tricuspidata leaf extracts along with the associated chemical factors. In in vitro CYP inhibition assays, C. tricuspidata leaf extracts exhibited potent inhibition of CYP1A2 and CYP2C8, with quercetin, kaempferol, and their glycosides identified as the major constituents. In silico analysis based on the prediction tools (ADMETlab 2.0 and pkCSM) identified key contributors to CYP inhibition, quercetin and kaempferol. Additionally, molecular docking analysis validated the binding of ligands (quercetin and kaempferol) to proteins (CYP1A2 and CYP2C8). These findings suggest that C. tricuspidata leaf extracts could inhibit CYP1A2 and CYP2C8, aiding in understanding the herb-drug interaction potential of C. tricuspidata leaf extracts for safe clinical application. Furthermore, this approach can be broadly applied to study herb-drug interactions of various medicinal herbs, enhancing their therapeutic benefits and reducing adverse reactions by considering chemical profiles relevant to herb-drug interaction potential in herbal preparations.
引用
收藏
页码:858 / 863
页数:6
相关论文
共 34 条
  • [1] Hepatoprotective compounds of the roots of Cudrania tricuspidata on tacrine-induced cytotoxicity in Hep G2 cells
    An, RB
    Sohn, DH
    Kim, YC
    [J]. BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2006, 29 (04) : 838 - 840
  • [2] Critical evaluation of causality assessment of herb-drug interactions in patients
    Awortwe, Charles
    Makiwane, Memela
    Reuter, Helmuth
    Muller, Christo
    Louw, Johan
    Rosenkranz, Bernd
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 84 (04) : 679 - 693
  • [3] The role of metabolism (and the microbiome) in defining the clinical efficacy of dietary flavonoids
    Cassidy, Aedin
    Minihane, Anne-Marie
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 2017, 105 (01) : 10 - 22
  • [4] Interaction between phytotherapy and oral anticancer agents: prospective study and literature review
    Clairet, Anne-Laure
    Boiteux-Jurain, Marie
    Curtit, Elsa
    Jeannin, Marie
    Gerard, Blandine
    Nerich, Virginie
    Limat, Samuel
    [J]. MEDICAL ONCOLOGY, 2019, 36 (05)
  • [5] Cytochrome P450 2C8 pharmacogenetics: a review of clinical studies
    Daily, Elizabeth B.
    Aquilante, Christina L.
    [J]. PHARMACOGENOMICS, 2009, 10 (09) : 1489 - 1510
  • [6] Progress in molecular docking
    Fan, Jiyu
    Fu, Ailing
    Zhang, Le
    [J]. QUANTITATIVE BIOLOGY, 2019, 7 (02) : 83 - 89
  • [7] Inhibition and induction of CYP enzymes in humans: an update
    Hakkola, Jukka
    Hukkanen, Janne
    Turpeinen, Miia
    Pelkonen, Olavi
    [J]. ARCHIVES OF TOXICOLOGY, 2020, 94 (11) : 3671 - 3722
  • [8] Herbal Medicine for Pain Management: Efficacy and Drug Interactions
    Jahromi, Behdad
    Pirvulescu, Iulia
    Candido, Kenneth D.
    Knezevic, Nebojsa Nick
    [J]. PHARMACEUTICS, 2021, 13 (02) : 1 - 43
  • [9] Jia Lei, 2022, Methods Mol Biol, V2390, P447, DOI 10.1007/978-1-0716-1787-8_20
  • [10] KIM DH, 2016, BIOMED RES INT, V2016, DOI DOI 10.1155/2016/8432759